GC Green Cross Wellbeing announced on July 7 that it participated in the "ASLS TOKYO 2026," the Japan conference of the Korean Academy of Aesthetic Laser Medicine, held in Tokyo, Japan on June 28, and launched marketing activities targeting the global aesthetics market.


GC Green Cross Wellbeing Introduces ECM Skin Booster 'Rebona' at ASLS TOKYO 2026. GC Green Cross Wellbeing

GC Green Cross Wellbeing Introduces ECM Skin Booster 'Rebona' at ASLS TOKYO 2026. GC Green Cross Wellbeing

View original image

This global academic conference, hosted by the Korean Academy of Aesthetic Laser Medicine, brought together more than 30 major companies, including global leaders in the medical aesthetics industry, and was attended by over 500 aesthetic medicine professionals and industry stakeholders from across Asia.


At the conference, GC Green Cross Wellbeing operated a joint promotional booth with its official local Japanese partner, "Nifuji," to showcase its flagship ECM (Extracellular Matrix) product "Rebornne." "Rebornne," which goes through a rigorous validation process and a safe decellularization procedure, is characterized by the use of proprietary collagen fragmentation technology to create uniform micro-particles.


During the conference, approximately 100 local Japanese physicians visited the booth to receive explanations about Rebornne and the placenta injection "Laennec," and expressed their anticipation for the upcoming "Second Japan Local Seminar," according to the company.


The conference also featured an academic lecture dedicated to Rebornne. Kyunghoon Yoo, director of Lumi Clinic, gave a presentation titled "ADM-Based ECM Therapy - A Rapid-Response Injection & Layering Strategy," introducing a procedural guide and the clinical utility of Rebornne.


GC Green Cross Wellbeing also unveiled its next-generation aesthetic lineup, "Giselle PDRN 2.5" and "Giselle PDRN 2.0," at the conference.



A representative from GC Green Cross Wellbeing stated, "It was a meaningful occasion to solidify our partnerships in the Japanese market and significantly enhance our brand awareness through proactive academic marketing targeting local medical professionals. Moving forward, we will continue to accelerate the development and expansion of our presence in the global aesthetic medicine market through customized academic activities and a differentiated lineup tailored for overseas markets."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing